Zhangzhou Pientzehuang Pharmaceutical Co Ltd Financial Flexibility Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd financial flexibility index. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥174.25 Million (operating CF CN¥117.38 Million minus capex CN¥56.87 Million) represents 0% of total liabilities (CN¥2.44 Billion). Explore capital reinvestment ratio of Zhangzhou Pientzehuang Pharmaceutical Co to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Financial flexibility index of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. Historical Financial Flexibility Index trend for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 25 annual periods. Check 600436 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Financial Flexibility Index by Year (2001–2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhangzhou Pientzehuang Pharmaceutical Co cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥416.82 Million | CN¥77.03 Million | CN¥2.47 Billion | ▼ -80.9% |
| 2024 | 0.88x | CN¥2.38 Billion | CN¥1.31 Billion | CN¥2.70 Billion | ▲ +18.7% |
| 2023 | 0.74x | CN¥2.35 Billion | CN¥2.21 Billion | CN¥3.16 Billion | ▼ -70.7% |
| 2022 | 2.54x | CN¥7.05 Billion | CN¥6.87 Billion | CN¥2.78 Billion | ▲ +978.6% |
| 2021 | 0.24x | CN¥554.44 Million | CN¥462.27 Million | CN¥2.36 Billion | ▼ -75.7% |
| 2020 | 0.97x | CN¥1.89 Billion | CN¥1.47 Billion | CN¥1.95 Billion | ▲ +318.9% |
| 2019 | -0.44x | CN¥-813.94 Million | CN¥-879.37 Million | CN¥1.84 Billion | ▼ -186.9% |
| 2018 | 0.51x | CN¥686.55 Million | CN¥612.31 Million | CN¥1.35 Billion | ▼ -14.7% |
| 2017 | 0.60x | CN¥728.80 Million | CN¥676.93 Million | CN¥1.22 Billion | ▲ +58.0% |
| 2016 | 0.38x | CN¥485.51 Million | CN¥394.54 Million | CN¥1.29 Billion | ▼ -26.2% |
| 2015 | 0.51x | CN¥384.37 Million | CN¥305.51 Million | CN¥751.60 Million | ▲ +16.7% |
| 2014 | 0.44x | CN¥290.36 Million | CN¥264.50 Million | CN¥662.34 Million | ▼ -30.5% |
| 2013 | 0.63x | CN¥420.88 Million | CN¥274.34 Million | CN¥667.05 Million | ▲ +34.1% |
| 2012 | 0.47x | CN¥317.62 Million | CN¥162.40 Million | CN¥675.22 Million | ▼ -33.5% |
| 2011 | 0.71x | CN¥268.51 Million | CN¥232.95 Million | CN¥379.69 Million | ▲ +5.1% |
| 2010 | 0.67x | CN¥244.31 Million | CN¥205.41 Million | CN¥362.97 Million | ▲ +80.7% |
| 2009 | 0.37x | CN¥159.19 Million | CN¥129.52 Million | CN¥427.35 Million | ▲ +66.9% |
| 2008 | 0.22x | CN¥71.08 Million | CN¥12.57 Million | CN¥318.45 Million | ▼ -71.6% |
| 2007 | 0.79x | CN¥166.50 Million | CN¥60.04 Million | CN¥212.03 Million | ▲ +44.8% |
| 2006 | 0.54x | CN¥59.41 Million | CN¥50.70 Million | CN¥109.53 Million | ▼ -55.2% |
| 2005 | 1.21x | CN¥103.59 Million | CN¥69.06 Million | CN¥85.56 Million | ▼ -78.2% |
| 2004 | 5.56x | CN¥109.42 Million | CN¥98.67 Million | CN¥19.69 Million | ▲ +380.1% |
| 2003 | 1.16x | CN¥47.92 Million | CN¥32.36 Million | CN¥41.40 Million | ▲ +71.8% |
| 2002 | 0.67x | CN¥115.22 Million | CN¥105.45 Million | CN¥170.99 Million | ▲ +8.1% |
| 2001 | 0.62x | CN¥77.49 Million | CN¥65.84 Million | CN¥124.34 Million | — |